Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements

Clinical trial NCT05565794 · TERMINATED

Trial details

NCT number: NCT05565794
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma FGFR2 Gene Mutation FGFR2 Gene Rearrangement FGFR2 Gene Translocation

Start date: 2022-11-11
Primary completion: 2025-03-27
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.